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Abstract
Background: Heath facility-based sentinel site surveillance has been proposed as a means of monitoring trends in malaria
morbidity but may also provide an opportunity to improve malaria case management. Here we described the impact of a
sentinel site malaria surveillance system on promoting laboratory testing and rational antimalarial drug use.
Methodology/Principal Findings: Sentinel site malaria surveillance was established at six health facilities in Uganda
between September 2006 and January 2007. Data were collected from all patients presenting to the outpatient
departments including demographics, laboratory results, diagnoses, and treatments prescribed. Between the start of
surveillance and March 2010, a total 424,701 patients were seen of which 229,375 (54%) were suspected of having malaria.
Comparing the first three months with the last three months of surveillance, the proportion of patients with suspected
malaria who underwent diagnostic testing increased from 39% to 97% (p,0.001). The proportion of patients with an
appropriate decision to prescribe antimalarial therapy (positive test result prescribed, negative test result not prescribed)
increased from 64% to 95% (p,0.001). The proportion of patients appropriately prescribed antimalarial therapy who were
prescribed the recommended first-line regimen artemether-lumefantrine increased from 48% to 69% (p,0.001).
Conclusions/Significance: The establishment of a sentinel site malaria surveillance system in Uganda achieved almost
universal utilization of diagnostic testing in patients with suspected malaria and appropriate decisions to prescribed
antimalarial based on test results. Less success was achieved in promoting prescribing practice for the recommended first-
line therapy. This system could provide a model for improving malaria case management in other health facilities in Africa.
Citation: Sserwanga A, Harris JC, Kigozi R, Menon M, Bukirwa H, et al. (2011) Improved Malaria Case Management through the Implementation of a Health
Facility-Based Sentinel Site Surveillance System in Uganda. PLoS ONE 6(1): e16316. doi:10.1371/journal.pone.0016316
Editor: Steffen Borrmann, Kenya Medical Research Institute - Wellcome Trust Research Programme, Kenya
Received September 15, 2010; Accepted December 11, 2010; Published January 19, 2011
Copyright:  2011 Sserwanga et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study received financial support from the President’s Malaria Initiative through a cooperative agreement with the Centers for Disease Control and
Prevention (U50/CCU925122). JH was supported in part by an Institutional Research Training Grant (T32MH019105) from the National Institute of Mental Health.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the
National Institutes of Health. The funding agencies had no role in the design and conduct of the study; collection, management, and analysis of the data. The
findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Members of the Centers for Disease Control and Prevention (MM, SN, and SF) were involved in the preparation, review, and approval of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gdorsey@medsfgh.ucsf.edu
Introduction
Malaria surveillance is essential to guide program planning and
management, inform governments and donors on progress
towards malaria control, and assist with advocacy. Surveillance
also provides the basis for the design, refinement and resource
allocation of control programs [1,2]. Most malaria control
programs in Africa rely on routinely collected health facility-based
data for surveillance needs as part of a country’s Health
Management Information Services (HMIS). The methods used
to collect data at health facilities vary widely and are highly subject
to bias, as there are many factors that influence whether a patient
with malaria will be captured by this system [3]. In addition,
health facility data may be inaccurate due to lack of reporting
and/or the absence of laboratory confirmation of diagnoses.
Indeed, national reports on trends in malaria cases from most
countries in Africa simply reflect the number of unconfirmed cases
captured through the HMIS system [3]. The slide positivity rate
(SPR), defined as the number of laboratory-confirmed malaria
cases per 100 suspected cases examined, provides an alternative
method for estimating temporal changes in malaria morbidity.
The SPR gains accuracy in considering only laboratory confirmed
cases of malaria, and it can provide a rapid and inexpensive means
of assessing the burden of malaria in a population utilizing health
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care facilities. However, the SPR is subject to bias and is
dependent on a number of factors influencing whether a suspected
case undergoes laboratory testing and test results are accurately
measured and reported. Decreases in the SPR have been cited as
evidence for successful malaria control interventions in Africa
[4,5].
Unfortunately most health facilities in Africa currently lack the
capacity to generate accurate data on malaria cases based on
laboratory confirmation [3]. Sentinel site surveillance has been
proposed as a practical means of improving the quality of malaria
surveillance data in Africa at selected health facilities [6]. Sentinel
sites are health facilities from a limited number of geographically
defined areas selected to produce high quality malaria surveillance
data based on laboratory confirmed cases. In addition to
improving the accuracy of malaria surveillance data, laboratory
confirmed diagnosis may promote the rational use of antimalarial
therapy and improve patient care. Indeed, recently published
guidelines from the World Health Organization (WHO) now
recommend a laboratory confirmation of diagnosis in all patients
suspected of having malaria before treating [7]. This updated
approach to malaria case management follows the widespread
adoption of highly effective but relatively expensive artemisinin-
based combination therapy (ACT), signifying a need for restricted
and better targeted treatment of malaria.
In 2006, the Uganda Malaria Surveillance Project (UMSP) in
collaboration with the Ugandan Ministry of Health established a
sentinel site malaria surveillance system with support from the
U.S. President’s Malaria Initiative. Sites were purposefully selected
to represent the varying epidemiology of malaria in Uganda. The
primary objective of this surveillance system was to provide a
means of accurately monitoring trends in malaria morbidity based
on the SPR. However, establishing this system also provided an
opportunity to improve the utilization of diagnostic testing and
promote the rational use of antimalarial therapy. Data were
previously published on the impact of a focused short-course
training program on malaria case management 3–6 months
following the establishment of the surveillance system [8]. Here we
describe the maintenance of the UMSP sentinel site surveillance
system and the longer-term impact that this had on malaria case
management over 3 years following its implementation
Methods
Establishment of health facility-based surveillance system
and study sites
UMSP in collaboration with the Uganda National Malaria
Control Program (NMCP) established a health facility-based
malaria surveillance system at six sentinel sites between September
2006 and January 2007 (Figure 1). All sentinel site facilities are
government run level IV health centers that provide care free of
charge, including diagnostic testing and medications. Level IV
health centers generally have a catchment population of
approximately 100,000 people and are staffed by one medical
officer, two clinical officers, five nurses, five midwives, four nursing
assistants, one dental officer, one lab technician, one lab assistant,
one records officer, one health educator and one health assistant.
Each site had previously been selected as part of the East African
Network for Monitoring Antimalarial Treatment (EANMAT) to
represent the diversity of geography and malaria transmission
intensity in Uganda [9].
Data collection and management
Methods developed to collect data were part of an iterative and
collaborative process between UMSP and the Uganda HMIS.
Unlike the traditional HMIS, the new data collection system
provided individual-level data on all patients presenting to the
outpatient department of the sentinel site facilities. Data collected
included patient demographic information, basic clinical informa-
tion, laboratory results, diagnoses, and treatments prescribed.
Data collection instruments evolved from written clinical and
laboratory log books to a single standardized case record form
(CRF) completed for each patient and characterized by tick boxes
and lists of options to minimize transcription errors (Appendix S1).
Data collection instruments were initially transported to a core
facility in the capital city of Kampala for electronic data entry
using Access (Microsoft Corporation, Redmond, WA). Over time
this system advanced to where UMSP employed data officers
entered the data electronically using Epi Info version 3.5.1
(Centers for Disease Control and Prevention, Atlanta, GA) at the
sites and sent it remotely once a month via cellular phone
technology to a core facility in Kampala for uploading to a SQL
server (Microsoft Corporation, Redmond, WA). Data officers were
the only direct staff supported by UMSP at the sentinel sites. A
public website exists (http://umsp.muucsf.org) where standardized
tables and figures can be generated to monitor trends in key
indicators and monthly reports are posted.
Training and quality assurance
Staff at the sentinel site facilities underwent a six-day training
course 3–6 months following the initiation of the surveillance
program to improve health workers’ performance of clinical and
laboratory tasks relevant to malaria case management. The
curriculum and training materials were developed and delivered
through the Joint Uganda Malaria Training Program (JUMP), a
partnership between UMSP and the Infectious Diseases Institute
(IDI) of Makerere University, the details of which have been
previously published [8]. The course was team-based and targeted
three categories of staff typically working in health facilities in
Uganda: clinicians (medical officers, clinical officers, nurses and
midwives), laboratory staff, and records clerks. The course
included both didactic and practical hands-on sessions. Two
follow-up support supervision visits, approximately 6 and 12 weeks
after the initial training course, were conducted at the sentinel sites
by JUMP team members to reinforce training messages, assess
skills, and provide individual feedback.
Following the formal training program, the UMSP surveillance
team consisting of clinical, laboratory, and data officers visited the
sites every 1–2 months to ensure an adequate supply of CRFs and
laboratory consumables and provide feedback to staff. Feedback
included review of overall site performance relative to quality
assurance/quality control targets. In addition, workshops were
held with district leaders in collaboration with representatives of
the NMCP to build support for the project. Supervision and
funding of all site visits and workshops were provided by UMSP.
The project did not have any influence over drug supplies or the
monitoring of stock outs.
Malaria case management indicators and statistical
analysis
The primary purpose of the surveillance project was to monitor
trends in malaria morbidity. However, a successful surveillance
program also provides the opportunity to improve malaria case
management, which was the focus of this report. Three key
indicators of malaria case management were evaluated (Figure 2):
1) proportion of patients with suspected malaria with a diagnostic
test done (microscopy or RDT); (suspected malaria was defined as
all patients referred for malaria laboratory testing plus all patients
not referred for a malaria laboratory test but given a clinical
Malaria Sentinel Site Surveillance
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diagnosis of malaria); 2) proportion of patients with a diagnostic
test done with appropriate decision to prescribe antimalarial
therapy (defined as either prescribing antimalarial therapy if the
result of the diagnostic test was positive or not prescribing
antimalarial therapy if the result of the diagnostic test was
negative); 3) proportion of patients appropriately prescribed
antimalarial therapy (antimalarial prescribed with a positive
diagnostic test result) who were prescribed artemether-lumefan-
trine (AL), the recommended 1st-line therapy for uncomplicated
malaria in Uganda since 2005.
Data were included from the time surveillance began through
March 2010, with the exception of May 2007 – August 2008 at
one site (Kamwezi) when surveillance was interrupted due to
administrative difficulties. Proportions during the first three
months of surveillance were compared with the last three months
(January – March 2010) using the non-parametric McNemar’s
test. A p-value ,0.05 was considered statistically significant.
Results
Descriptive data
Quarterly aggregate data for all sites actively participating in the
surveillance project are presented in Table 1. A total of 424,701
patients were seen at the six sites during a total of 232 months of
data collection. The average number of patients seen per month
ranged from 968 (Kasmbya) to 2,488 (Kamwezi), and was fairly
consistent during the observation period with the exception of
Kamwezi where the average number of patients seen per month
increased almost 2-fold following May 2009 (1,907 vs. 3,476) due
to a presumed malaria epidemic in the southwest part of the
country. Overall, 229,375 patients evaluated had suspected
malaria (54%); this proportion ranged from 47% (Aduku) to
64% (Kasambya). The proportion of diagnostic tests that were
positive for malaria parasites was 40% and ranged from 33%
(Kihihi) to 55% (Aduku). The proportion of patients seen with
suspected malaria and the proportion of diagnostic tests that were
positive were fairly consistent over the observation period at all of
the sites with the exception of Kamwezi, where suspected malaria
cases increased from 35% to 59% and the proportion of positive
diagnostic tests increased from 26% to 50% following the
presumed malaria epidemic in May 2009.
Diagnostic testing
A total of 166,278 patients underwent diagnostic testing for
malaria parasites over the observation period (Table 1). Micros-
copy and RDTs made up 84% and 16% of diagnostic tests
performed, respectively. The use of RDTs first became available in
January 2009 and RDTs were only used at four of the six sites. A
majority of RDT usage came from a single site (Kamwezi) where
this made up 89% of diagnostic testing done starting in January
Figure 1. Map of the districts, government health centers, and dates of initiation for the UMSP sentinel sites.
doi:10.1371/journal.pone.0016316.g001
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2009. At another site (Kihihi) RDTs made up 75% of diagnostic
testing done between April 2009 and January 2010 when supplies
were exhausted. In two other sites RDTs made up 16%
(Nagongera) and 5% (Kasambya) of diagnostic testing during the
brief periods they were available (May – December 2009 and
November 2009 – February 2010, respectively).
The proportion of patients with suspected malaria who
underwent diagnostic testing increased from 39% during the first
three months of surveillance (range 28–64% at the six sites) to 97%
during the last three months of observation (range 94–99% at the
six sites) resulting in an absolute increase of 58% (95% CI 57–
59%, p,0.001). Temporal changes in the proportion of patients
with suspected malaria undergoing diagnostic testing are presented
in Figure 3. Five of the six sites had a significant increase following
the JUMP training program, however several of the sites had
subsequent periods of decline or minimal improvement in the year
following training. Over the last year of the observation period all
of the sites showed improvement, reaching at least 94% success in
obtaining laboratory testing for patients with suspected malaria.
Antimalarial treatment practices
The proportion of patients with a diagnostic test done with an
appropriate decision to prescribe antimalarial therapy increased
from 64% during the first three months of surveillance (range 51–
78% at the six sites) to 95% during the last three months of
observation (range 89–98% at the six sites) resulting in an absolute
increase of 30% (95% CI 29–31%, p,0.001). Temporal changes
in the proportion of patients with a diagnostic test done with an
 
 
 
  
 
Figure 2. Malaria case management decision algorithm. Numbers highlight the three key indicators of malaria case management evaluated.
doi:10.1371/journal.pone.0016316.g002
Malaria Sentinel Site Surveillance
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e16316
appropriate decision to prescribe antimalarial therapy are
presented in Figure 4. Most sites showed initial improvement
following the JUMP training program followed by a period of
decline or relatively little change followed by gradual improvement
again during the last year of observation.
Making an appropriate decision to prescribe antimalarial
therapy can be divided into prescribing antimalarial therapy in
those with a positive diagnostic test and not prescribing
antimalarial therapy in those with a negative diagnostic test.
Although there was significant improvement in the proportion of
those with a positive diagnostic test prescribed antimalarial
therapy when comparing the first three months with the last three
months (90% vs. 98%, p,0.001), the biggest improvement was in
the proportion of patients with a negative diagnostic test not
prescribed antimalarial therapy (46% vs. 91%, p,0.001).
The proportion of patients appropriately prescribed antimalarial
therapy who were prescribed AL showed a modest increase from
48% during the first three months of surveillance (range 36–84% at
the six sites) to 69% during the last three months of observation
(range 35–92% at the six sites) resulting in an absolute increase of
20% (95% CI 18–23%, p,0.001). Temporal changes in the
proportion of patients appropriately prescribed antimalarial therapy
who were prescribed AL are presented in Figure 5. Unlike the other
indicators of malaria case management which showed clear
improvement over time, trends in AL prescribing practices varied
widely over time and between sites. Three sites showed an overall
Table 1. Absolute numbers and proportions for key steps in malaria case management algorithm (all sites combined).
Time period
Number
of active
sites
Malaria
suspected (%)
Laboratory
test done (%)
Positive
laboratory
test (%)
Appropriate
decision to
prescribe
antimalarial (%) Prescribed AL (%)
Total
patients
seen
Malaria
suspected
Laboratory
test done
Laboratory test
done
Appropriately
prescribed
antimalarial therapy
Aug-Sep 06 2 2,953 (59%) 1,659 (56%) 579 (35%) 1,008 (61%) 228 (49%)
5,038 2,953 1,659 1,659 469
Oct-Dec 06 4 8,287 (51%) 4,417 (53%) 1,635 (37%) 3,404 (77%) 954 (72%)
16,254 8,287 4,417 4,417 1,322
Jan-Mar 07 6 19,384 (57%) 8,836 (46%) 3,695 (42%) 6,721 (76%) 1,880 (58%)
23,778 19,384 8,836 8,836 3,253
Apr-Jun 07 6 12,766 (46%) 6,616 (52%) 2,356 (36%) 5,675 (86%) 1,381 (63%)
27,851 12,766 6,616 6,616 2,200
Jul-Sep 07 5 11,078 (48%) 6,289 (57%) 2,876 (46%) 5,577 (89%) 1,248 (46%)
23,138 11,078 6,289 6,289 2,737
Oct-Dec 07 5 10,756 (49%) 6,416 (60%) 1,849 (29%) 5,765 (90%) 1,480 (84%)
21,888 10,756 6,416 6,416 1,764
Jan-Mar 08 5 11,212 (50%) 6,264 (56%) 2,117 (34%) 5,547 (89%) 1,788 (87%)
22,540 11,212 6,264 6,264 2,048
Apr-Jun 08 5 13,837 (54%) 8,448 (61%) 3,528 (42%) 7,612 (90%) 2,972 (89%)
25,393 13,837 8,448 8,448 3,339
Jul-Sep 08 6 12,433 (51%) 7,670 (62%) 2,841 (37%) 6,421 (84%) 2,079 (82%)
24,527 12,433 7,670 7,670 2,542
Oct-Dec 08 6 17,303 (49%) 12,081 (70%) 4,136 (34%) 10,277 (85%) 2,657 (68%)
35,097 17,303 12,081 12,081 3,889
Jan-Mar 09 6 15,038 (48%) 11,388 (76%) 3,961 (35%) 9,673 (85%) 2,258 (59%)
31,181 15,038 11,388 11,388 3,826
Apr-Jun 09 6 18,608 (52%) 15,125 (81%) 6,070 (40%) 13,488 (89%) 3,415 (58%)
35,686 18,608 15,125 15,125 5,888
Jul-Sep 09 6 21,554 (53%) 19,333 (90%) 7,549 (39%) 17,974 (93%) 4,659 (63%)
40,309 21,554 19,333 19,333 7,349
Oct-Dec 09 6 26,342 (64%) 24,836 (94%) 11,983 (48%) 23,413 (94%) 9,427 (80%)
41,432 26,342 24,836 24,836 11,817
Jan-Mar 10 6 27,824 (69%) 26,900 (97%) 12,123 (45%) 25,447 (95%) 8,182 (69%)
40,589 27,824 26,900 26,900 11,929
Totals - 229,375 (54%) 166,278 (72%) 67,298 (40%) 148,002 (89%) 44,608 (69%)
424,701 229,375 166,278 166,278 64,372
doi:10.1371/journal.pone.0016316.t001
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Figure 3. Proportion of patients with suspected malaria with a diagnostic test done by quarter and stratified by site.
doi:10.1371/journal.pone.0016316.g003
Figure 4. Proportion of patients with diagnostic test done with appropriate decision to prescribe antimalarial therapy by quarter
and stratified by site.
doi:10.1371/journal.pone.0016316.g004
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improvement, but did have periods of substantial decline. Two sites
showed minimal or no improvement and one site showed a
significant decline in the proportion of patients prescribed AL. Of
note, less than 2% of patients appropriately prescribed AL were also
prescribed another antimalarial drug. Among those with a positive
laboratory test result who were not prescribed AL, the most
common antimalarials prescribed were quinine (80%) and a
combination of chloroquine plus sulfadoxine-pyrimethamine (14%).
Discussion
During the implementation of a health facility based surveil-
lance system, there were significant improvements in several key
steps of malaria case management at the six sentinel sites. The
biggest impact was in the proportion of patients with suspected
malaria who were referred for diagnostic testing. At the onset of
the surveillance system a majority of suspected malaria cases were
treated empirically without referral for diagnostic testing. Howev-
er, utilization of laboratory service greatly improved as 97% of
patients with suspected malaria were referred for diagnostic testing
during the final three months of evaluation. Treatment practices
were also significantly improved in terms of not prescribing
antimalarials in patients with negative diagnostic tests, prescribing
antimalarials in patients with positive diagnostic tests, and
prescribing AL for patients with laboratory confirmed malaria.
The quantitative impact of the surveillance system can be
estimated using a simple hypothetical approach comparing
observed malaria treatment practices with expected treatment
practices assuming no changes in our key indicators after the first
three months of observation. Between September 2006 and March
2010, a total of 229,375 cases of suspected malaria were captured
by the UMSP surveillance system. Assuming the proportion of
patients suspected of malaria with a lab test done and the
proportion of patients prescribed antimalarials with positive and
negative lab tests would have continued at the same level as the
first three months of data collection, the implementation of the
surveillance system resulted in 58,678 fewer antimalarial treat-
ments prescribed. In addition, the UMSP almost doubled the
number of prescriptions of antimalarials for lab confirmed cases of
malaria (32,505 expected vs. 64,366 observed).
The first critical step for improving malaria case management is
the referral of patients with suspected malaria for laboratory
diagnostic testing. Several studies from Africa have reported less
than 50% of patients suspected of having malaria undergo diagnostic
testing even when these services are available [10,11,12]. The
surveillance program described here benefitted from a six-day
integrated team-based training course of health care workers
conducted shortly after the program was implemented. However,
even after this training course, the proportion of suspected malaria
cases referred for laboratory testing remained just over 50% [9]. It
was not until after over three years of ongoing surveillance and
continued supervisory visits that consistent levels of over 90% of
suspected malaria cases referred for laboratory testing at all the sites
were achieved. Several lessons were learned over the course of these
three years. Patience was required as empiric treatment of malaria
without diagnostic testing has historically been part of the national
policy in most African countries and deeply ingrained in the teaching
of health care workers. Indeed, it is only in the last year that the
WHO has made a clear recommendation for the laboratory
confirmation of diagnosis in all patients suspected of having malaria
before treating in situations where diagnostic testing is available [7].
Another important factor was support from the UgandanMinistry of
Figure 5. Proportion of patients appropriately prescribed an antimalarial who were prescribed AL by quarter and stratified by site.
doi:10.1371/journal.pone.0016316.g005
Malaria Sentinel Site Surveillance
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16316
Health and district focal persons in advocating for the utilization of
laboratory services. Feedback and setting targets were also important
for encouraging health care workers and building confidence in the
value of having a test result for making treatment decisions. Finally,
ensuring the laboratories at the sentinel sites were well equipped to
handle the large numbers of patients referred for laboratory testing
was essential. At most of the sites this primarily involved support for
microscopy, which included advocating for adequate laboratory
personnel and ensuring adequate supplies needed for making blood
smears. At some of the sites, the utilization of RDTs also played a
role, especially in areas of unstable transmission intensity where the
need for diagnostic testing can fluctuate, and at times overwhelm the
capacity for microscopy. However, the role of RDTs was limited by
their availability.
The primary objective of the surveillance program was to
generate unbiased and precise estimates of the SPR by increasing
the utilization of diagnostic testing among cases of suspected
malaria. These data are provided to the Ministry of Health and
other stakeholders in the form of monthly reports which are also
posted on a public website (http://umsp.muucsf.org/). Although
evaluations of trends in SPR were beyond the scope of this report,
increasing the use of diagnostic testing provided an opportunity to
evaluate the impact of the surveillance program on improving
antimalarial treatment practices. The use of diagnostic testing may
improve patient care in parasite-positive patients, allow for the
identification of parasite-negative patients in whom another
diagnosis should be sought, reduce the use of unnecessary
antimalarials, and provide confirmation of treatment failures.
Approximately 1 in 10 patients with a positive diagnostic test were
not prescribed antimalarials during the initial period of the
surveillance program. This appeared to be due to clinicians making
decisions about treatment prior to receiving the diagnostic test
results based on informal discussions with clinic staff. Through
continuous training and supervisory visits, clinicians were encour-
aged to wait for the laboratory result before making treatment
decisions resulting in a significant reduction in the proportion of
parasite-positive patients not prescribed an antimalarial. A much
more common problem early in the surveillance program was the
practice of prescribing antimalarials in patients with a negative
diagnostic test. Indeed, studies across a wide range of epidemiologic
setting in Africa have documented that 35–79% of patients with
negative diagnostic test result were still prescribed antimalarial
drugs [11,12,13,14]. This seemingly irrational treatment practice
can be difficult to change as demonstrated by a study in Tanzania
where the introduction of RDTs and basic training did not lead to a
reduction in overuse of antimalarial drugs [15].
In this surveillance program, the proportion of patients with a
diagnostic test done who were appropriately prescribed antima-
larial therapy increased after the JUMP training program,
however, some sites failed to sustain these improvements or
showed declines. Only after three years of the surveillance
program were we able to reach levels greater than 90%, although
two sites continue to prescribe antimalarials in up to 20% of
patients with a negative diagnostic test. Again, promoting rational
antimalarial treatment practices took patience, continual feedback
to the health care providers, and support from government
officials at the Ministry of Health and district level. In the era of
ACTs, limiting the unnecessary use of antimalarials becomes a
high priority as this will help maintain drug supplies, reduces
health system costs [16,17], and might reduce opportunities for the
selection of drug resistant parasites. The surveillance program was
less successful in promoting the use of AL in parasite-positive
patients. Although there were some modest gains, AL treatment
practices varied widely over time and between sites. Although data
on the reasons for not prescribing AL were not collected
systematically, informal discussions with health care workers
suggested that the primary factor responsible was drug stock-outs.
As ACTs are being rolled out in large numbers around Africa, the
ability to maintain a consistent drug supply has become a major
issue and has been cited as a major factor in health care workers
choice of antimalarials in Uganda and Kenya [18,19].
There are several important limitations of this study that should
be pointed out. The surveillance program was not implemented as
a controlled experiment, therefore causal inferences between the
intervention and improvement in indicators of improved malaria
case management should be made with caution. Secondly the
various components of the surveillance program were not
implemented in a systematic fashion. Rather improvements to
the program were made over time based on experience, need, and
a ‘‘trial and error’’ basis. Indeed, the surveillance program did not
establish a pre-specified list of qualitative or quantitative goals in
terms of interventions, but rather interventions were developed
and implemented as a means of continuously improving indicators
of malaria case management. Finally, data collected were limited
to the practices of health care workers and did not include exit
interviews or follow-up surveys. Therefore it is unknown whether
improvements in health care worker performance lead to
improved patient outcomes. Several ‘‘downstream’’ factors such
as proper dosing, successfully filling prescriptions, adherence to
medications, and treatment seeking practices after leaving the
clinic are all important for successful malaria case management.
In summary, although the absence of a ‘‘control group’’ limits
the ability to make causal inferences, the experience of UMSP
provides evidence for the utility of a health facility-based sentinel
site malaria surveillance system that produces high quality data in
Africa given that adequate resources are available. In addition to
improving the capacity to monitor trends in malaria morbidity and
measure the impact of control interventions in these selected sites,
there is added value by improving malaria case management for
large numbers of patients. Indeed, surveillance itself should be
considered an intervention and an integral part of any malaria
control program. Success of the program did not occur overnight,
but rather required patience, flexibility, feedback from heath care
workers, and continuous support from the government and
funding agency. Although the malaria surveillance program
described here has not been expanded beyond the sentinel site
health facilities, lessons learned from this program should benefit
other initiatives aimed at improving malaria case management in
other health care facilities and provides a demonstration project
for changing the practices of health care workers in Africa.
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